Bildkälla: Stockfoto

Xbrane Biopharma: Ximluci Approved in the EU - Redeye

Redeye leaves a short comment on today’s news that Xbrane and STADA have secured EU approval for Ximluci. Today’s announcement was expected, but it nevertheless marks a significant milestone for the company, and the Q1 2023 launch is nearing swiftly.

Redeye leaves a short comment on today’s news that Xbrane and STADA have secured EU approval for Ximluci. Today’s announcement was expected, but it nevertheless marks a significant milestone for the company, and the Q1 2023 launch is nearing swiftly.
Börsvärldens nyhetsbrev
ANNONSER